Product/Composition:- | Adefovir Dipivoxil |
---|---|
Strength:- | 10 mg |
Form:- | Oral tablets |
Reference Brands:- | Hepsera® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Adefovir Dipivoxil is a 10 mg oral antiviral used to treat chronic Hepatitis B infection by inhibiting viral DNA polymerase. Marketed as Hepsera®, it’s FDA and EMA approved and effective against lamivudine-resistant HBV. Widely used in the US and EU, it’s an essential drug for pharma B2B suppliers managing Hepatitis B treatments.
Adefovir Dipivoxil is an oral antiviral nucleotide analog used to treat chronic Hepatitis B virus (HBV) infection. Available as 10 mg tablets, it inhibits viral DNA polymerase, preventing HBV replication and reducing viral load. Marketed primarily as Hepsera® by Gilead Sciences, Adefovir Dipivoxil is FDA and EMA approved and widely prescribed in both the US and EU. It is especially effective for patients with lamivudine-resistant HBV strains. Pharma B2B suppliers rely on Adefovir Dipivoxil as a key medication in managing chronic Hepatitis B infections and improving patient outcomes.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications